FDA Inspection 1177937 — QuVa Pharma, Inc.
The FDA completed an inspection of QuVa Pharma, Inc. on Aug 18, 2022 in Sugar Land, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 18, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sugar Land, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1111 | 21 CFR 211.25(a) | Training , Education , Experience overall |
| 1912 | 21 CFR 211.166(a) | Written program not followed |
| 3611 | 21 CFR 211.160(b)(3) | Acceptance of drug products |